Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Autosomal recessive polycystic kidney disease (ARPKD) usually affects both the kidneys and the bile ducts within the liver. Tiny dilated kidney ducts can enlarge the kidneys and cause high blood pressure or reduced kidney function. Liver scarring and abnormal bile ducts can cause pressure in portal veins or infection, sometimes years after kidney disease appears. Severe cases present before birth or in infancy, but milder disease may be recognized later.
Clinical Definition
Classic ARPKD-PKHD1 is caused by biallelic pathogenic variants in PKHD1, encoding fibrocystin/polyductin. It combines fusiform collecting-duct dilatation with congenital hepatic fibrosis from biliary ductal plate malformation, sometimes with intrahepatic bile-duct dilatation (Caroli syndrome). Severe fetal kidney dysfunction can cause oligohydramnios and pulmonary hypoplasia; other patients present later with hypertension, CKD or portal hypertension. Kidney and liver severity vary independently. Rarer genetic causes and other ciliopathies can produce an ARPKD-like phenotype.